Free Trial

Medifast (MED) Stock Forecast & Price Target

$19.19
0.00 (0.00%)
(As of 10:42 AM ET)

Medifast - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$49.75
159.25% Upside
High Forecast$82.00
Average Forecast$49.75
Low Forecast$17.50
TypeCurrent Forecast
7/13/23 to 7/12/24
1 Month Ago
6/13/23 to 6/12/24
3 Months Ago
4/14/23 to 4/13/24
1 Year Ago
7/13/22 to 7/13/23
Consensus Rating
Reduce
Reduce
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$49.75$49.75$61.00$112.50
Forecasted Upside159.25% Upside5.19% Upside10.39% Upside-15.66% Downside
Get Medifast Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter.

MED Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MED Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Medifast Stock vs. The Competition

TypeMedifastConsumer Staples CompaniesS&P 500
Consensus Rating Score
1.50
2.43
2.50
Consensus RatingReduceHoldModerate Buy
Predicted Upside159.25% Upside748.89% Upside10.20% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/5/2024DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
L. Weiser
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeNeutral ➝ Underperform$25.00 ➝ $17.50-26.99%
10/13/2023Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageEqual Weight$82.00+16.11%
8/4/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$345.00 ➝ $150.00-12.59%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 11:09 AM ET.

MED Forecast - Frequently Asked Questions

What is Medifast's forecast for 2024?

According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Medifast is $49.75, with a high forecast of $82.00 and a low forecast of $17.50.

Should I buy or sell Medifast stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last twelve months. There is currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "reduce" MED shares.

Does Medifast's stock price have much upside?

According to analysts, Medifast's stock has a predicted upside of 5.19% based on their 12-month stock forecasts.

Has Medifast been downgraded by Wall Street analysts recently?

Over the previous 90 days, Medifast's stock had 1 downgrade by analysts.

What analysts cover Medifast?

Medifast has been rated by research analysts at DA Davidson in the past 90 days.

Do Wall Street analysts like Medifast more than its competitors?

Analysts like Medifast less than other "consumer staples" companies. The consensus rating for Medifast is Reduce while the average consensus rating for "consumer staples" companies is Hold. Learn more on how MED compares to other companies.


This page (NYSE:MED) was last updated on 7/12/2024 by MarketBeat.com Staff

From Our Partners